Lena Elisabeth Svanberg
Director/Board Member bij EGETIS THERAPEUTICS AB
Vermogen: 77 270 $ op 31-03-2024
Profiel
Lena Elisabeth Svanberg is currently serving as an Independent Non-Executive Director at Galapagos NV, Director at LEO Pharma A, Director at Leo Pharma, Inc., Independent Director at Egetis Therapeutics AB, Director at Amolyt Pharma SAS, Director at Epics Therapeutics SA, Chief Medical Officer at Kuste Biopharma SAS.
She has previously served as Chairman at Pharnext SA, Independent Director at Swedish Orphan Biovitrum AB, Director at Follicum AB, Director at The Swedish-American Chamber of Commerce, Inc., Head-Medical Affairs at Bristol Myers Squibb Co., and VP & Head-Established Products Group at Janssen Pharmaceuticals, Inc. Dr. Svanberg holds a doctorate degree from the University of Gothenburg.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GALAPAGOS NV
0.00% | 15-03-2024 | 1 883 ( 0.00% ) | 60 155 $ | 31-03-2024 |
EGETIS THERAPEUTICS AB
0.01% | 31-12-2022 | 27 396 ( 0.01% ) | 17 115 $ | 31-03-2024 |
Actieve functies van Lena Elisabeth Svanberg
| Bedrijven | Functie | Begin |
|---|---|---|
| EGETIS THERAPEUTICS AB | Director/Board Member | 01-01-2017 |
| GALAPAGOS NV | Director/Board Member | 28-04-2020 |
IXALTIS SAS
 IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Corporate Officer/Principal | 01-01-2016 |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Director/Board Member | 30-06-2021 |
Kuste Biopharma SAS
 Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Chief Tech/Sci/R&D Officer | 01-01-2020 |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Director/Board Member | - |
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Director/Board Member | - |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Director/Board Member | 01-01-2022 |
Eerdere bekende functies van Lena Elisabeth Svanberg
| Bedrijven | Functie | Einde |
|---|---|---|
| PHARNEXT SCA | Chairman | 30-03-2022 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Opleiding van Lena Elisabeth Svanberg
| University of Gothenburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| GALAPAGOS NV | Health Technology |
| PHARNEXT SCA | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| EGETIS THERAPEUTICS AB | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |
Follicum AB
 Follicum AB Pharmaceuticals: MajorHealth Technology Follicum AB is a biotech company, which engages in discovery and development of peptide-based drugs. Its product pipeline include FOL-005, FOL-00X, FOL-014, and FOL-00Y which is made for stimulation of hair growth and treatment of diabetes. The company was founded by Anna Kerstin Emy Hultgårdh Nilsson and Claes Pontus Dunér on May 3, 2011 and is headquartered in Lund, Sweden. | Health Technology |
The Swedish-American Chamber of Commerce, Inc.
 The Swedish-American Chamber of Commerce, Inc. Miscellaneous Commercial ServicesCommercial Services The Swedish-American Chamber of Commerce, Inc. is a business organization that provides contacts, partners, and business services to help businesses succeed in the United States. The non-profit company is based in New York, NY, with its office located at 900 3rd Avenue, 29th floor. The chamber offers memberships, marketing opportunities, and events and programming, including the largest transatlantic meet up for female leaders, entrepreneurs, and investors. With over 70 events and three large conferences arranged every year, the chamber's calendar most likely includes the right events for all business needs. | Commercial Services |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Health Technology |
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Health Technology |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Commercial Services |
Kuste Biopharma SAS
Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Health Technology |
